MarketPeel
Insider Trading Intelligence
AL

Alex C. Levit

CNTX
CHIEF LEGAL OFFICER, CORP. SEC · CONTEXT THERAPEUTICS INC. · CIK 0001862840
FILING MIX · LIFETIME100%/0%
BUYS
8
SELLS
0
TOTAL VALUE
$31.6K
COMPANIES
1
ACTIVE SINCE
Oct 2021
HOLDINGS NOW
270,000
AVG SELL PX
TRADE KIND
SHOWING 8 / 8
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
3 backtested trades · 8 horizons · 1 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Alex C. Levit, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d3+0.00%-11.23%-0.37%-10.86%-8.77%
14d3+0.00%-19.70%+0.13%-19.84%-21.90%
30d3+33.33%-8.89%+1.95%-10.85%-6.18%
60d3+66.67%-11.07%+4.47%-15.55%+0.59%
90d3+33.33%-19.80%+2.43%-22.23%-12.30%
180d3+66.67%+19.00%+7.44%+11.56%+49.99%
1y3+66.67%+27.06%+8.60%+18.46%-16.26%
2y3(1 pending)+50.00%-1.76%+26.98%-28.74%-28.74%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CNTX · 270,000 shares · as of Feb 19, 2026
087,475174,950262,425349,90020222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 8 buys / 0 sellsCOVERAGE · 18 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CNTX
CONTEXT THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
270,000270,000Feb 19, 2026Feb 23, 2026View →
CNTX
CONTEXT THERAPEUTICS INC.
PURCHASE
Chief Legal Officer, Corp. Sec
20,000$0.58$11.5K29,000Jun 6, 2025Jun 10, 2025View →
CNTX
CONTEXT THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
349,900349,900Feb 13, 2025Feb 14, 2025View →
CNTX
CONTEXT THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
153,515153,515Mar 21, 2024Mar 22, 2024View →
CNTX
CONTEXT THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
151,505151,505Feb 13, 2023Feb 14, 2023View →
CNTX
CONTEXT THERAPEUTICS INC.
PURCHASE
Chief Legal Officer, Corp. Sec
6,000$0.85$5.1K9,000Dec 9, 2022Dec 12, 2022View →
CNTX
CONTEXT THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
107,870107,870Feb 25, 2022Feb 25, 2022View →
CNTX
CONTEXT THERAPEUTICS INC.
PURCHASE
Chief Legal Officer, Corp. Sec
3,000$5.00$15.0K3,000Oct 22, 2021Oct 25, 2021View →
Other insiders · CNTX
Loading peer insiders…
About this filer
CIK 0001862840
ROLE
Chief Legal Officer, Corp. Sec
PRIMARY
CNTX
COMPANIES
1
ACTIVE SINCE
Oct 2021
MARKETPEEL · /INSIDER/0001862840DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback